The estimated Net Worth of Todd Rfwhc Holdings, Llc Wa... is at least $41.6 Million dollars as of 23 February 2022. Todd Wa owns over 41,608,884 units of H-CYTE stock worth over $41,608,884 and over the last 3 years Todd sold HCYT stock worth over $0.
Sign up
Todd Wa HCYT stock SEC Form 4 insiders trading
Todd has made over 1 trades of the H-CYTE stock since 2022, according to the Form 4 filled with the SEC. Most recently Todd exercised 41,608,884 units of HCYT stock worth $416,089 on 23 February 2022.
The largest trade Todd's ever made was exercising 41,608,884 units of H-CYTE stock on 23 February 2022 worth over $416,089. On average, Todd trades about 41,608,884 units every 0 days since 2022. As of 23 February 2022 Todd still owns at least 41,608,884 units of H-CYTE stock.
You can see the complete history of Todd Wa stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Todd Wa's mailing address?
Todd's mailing address filed with the SEC is 3385 OLD KEYSTONE ROAD1306 W KENNEDY BOULEVARD, , TARPON SPRINGSTAMPA, FLFL, 3468833606.
Insiders trading at H-CYTE
Over the last 6 years, insiders at H-CYTE have traded over $0 worth of H-CYTE stock and bought 60,000 units worth $8,050 . The most active insiders traders include Todd Rfwhc Holdings, Llc Wa..., J Rex Iiifwhc Holdings, Llc..., and Michael Yurkowsky. On average, H-CYTE executives and independent directors trade stock every 286 days with the average trade being worth of $10,590,590. The most recent stock trade was executed by J Rex Iiifwhc Holdings, Llc... on 23 February 2022, trading 693,477 units of HCYT stock currently worth $6,935.
What does H-CYTE do?
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute biologics for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
What does H-CYTE's logo look like?
Complete history of Todd Wa stock trades at H-CYTE
H-CYTE executives and stock owners
H-CYTE executives and other stock owners filed with the SEC include:
-
William Horne,
Chairman of the Board -
Robert Greif,
Pres -
Jeremy Daniel,
Chief Financial Officer -
Jeremy Daniel,
Chief Financial Officer -
Michael W. Yurkowsky,
CEO & Director -
Michael Yurkowsky,
Director -
Raymond Monteleone,
Director -
Robert Greifas,
President, Chief Executive Officer -
Dr. Tanya Rhodes Ph.D.,
Chief Technology Officer -
Jeffery Wright CPA, CPA,
Controller & Principal Accounting Officer -
J Rex Iiifwhc Holdings, Llc...,
-
Todd Rfwhc Holdings, Llc Wa...,
-
Frederick Jcfrs Investments...,
-
Robert Smith Greif,
Chief Executive Officer -
Todd Rfwhc Bridge, Llc Wagner,